Hull R D, Pineo G F
Department of Medicine, University of Calgary, Alberta, Canada.
Clin Chest Med. 1995 Jun;16(2):269-80.
The use of heparin and warfarin in the treatment of venous thromboembolism has been revolutionized by the findings of clinical trials performed over the past decade. This article addresses some unanswered questions regarding the treatment of venous thromboembolism that are the subjects of current clinical trials, such as the optimum duration of oral anticoagulant therapy in patients with idiopathic or recurrent deep vein thrombosis and the role of low-molecular-weight heparin in the short-term and long-term treatment of venous thrombosis.